Indian Drug Exporting Agency Seeks Helps For Domestic Pharmas
This article was originally published in PharmAsia News
Executive SummaryIndia's Pharmaceuticals Export Promotion Council says it is seeking lower interest rates for the pharmaceutical industry as well as extra promotion of its products abroad. The plans are part of a special package to curtail some of the losses drug makers are suffering during the slow economy and rising cost of raw materials. Pharmexcil is trying to attract more credit for domestic exporters. The industry itself wants loans at lower interest rates and easier terms. Several companies have complained that banks of all types have stopped lending. (Click here for more
You may also be interested in...
ConMed’s ambitions in orthopedics are to be the clinician’s support, develop differentiated offerings and avoid “me too” activity, before all notions of leading the market rankings.
Executives On The Move: Tech And Science Announcements At Orexo And Agios, And Board Changes At Accorda And RhoVac
Swedish pharma Orexo welcomes EVP, digital health and anti-cancer therapeutics firm Agios Pharmaceuticals announces Bristol-Myers Squibb exec as its next CSO. And a chair takes a seat at Accorda Therapeutics and RhoVac.
In 2018, the top 100 publicly listed and reportable medical device technology companies had global sales spanning from over $30bn to some $100m in the lower reaches. As the latest In Vivo Medtech 100 ranking shows, many of the major changes in value sales were linked to company restructurings. But there were some impressive organic gains too.